Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Caitlin E. Cox

November 30, 2022

RAPCO: Radial Artery Beats of Both RITA and Vein Grafting at 15 Years

News Conference News AHA 2022

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

Yael L. Maxwell

November 06, 2022

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Presentation TCT 2022

TCT 113: Predicting the Risk of In-hospital Major Adverse Cardiovascular Events in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO MACE Score

Presenter: Bahadir Simsek

September 17, 2022

News Daily News

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Yael L. Maxwell

September 14, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Industry News

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

July 20, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Lower 10-Year Mortality With Multiple Arterial CABG in Diabetes: ART

Yael L. Maxwell

June 28, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

News Conference News EuroPCR 2022

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

Yael L. Maxwell

May 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis

Caitlin E. Cox

May 19, 2022

Advertisement

December 2022 News Roundup

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

SCAD in Men: Canadian Study Sheds Light on Rare Condition

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

TCT 113: Predicting the Risk of In-hospital Major Adverse Cardiovascular Events in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO MACE Score

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Lower 10-Year Mortality With Multiple Arterial CABG in Diabetes: ART

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Fibromuscular Dysplasia in SCAD Tied to Worse Long-term Prognosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content